Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
5
2020
FDA’s Prescription Drug Advertising Enforcers Issue COVID-19-Related Warning Letter Mintz
Apr
19
2017
New State Substitution Laws, and a Busy Spring for Biosimilars Mintz
Apr
23
2024
CMS Publishes Final Rules Implementing Part C and Part D Program Changes Mintz
May
12
2017
The Past, Present, and Future of Government Regulation of Off-Label Communications – Part 2 Mintz
Jan
28
2021
Recent Amendments to the FDA Laws Attempt to Clarify and Improve Existing Systems Mintz
Jul
13
2017
FDA Delays Enforcement of Prescription Drug Product Identifier and Related Requirements Mintz
Aug
15
2017
The Past, Present, and Future of Government Regulation of Off-Label Communications – Part 3 Mintz
Mar
5
2012
Energy and Environment Update - March 4, 2012 Mintz
Apr
17
2012
MA Senate Bill Would Revise Incentives for Renewable Energy Development Mintz
Dec
11
2012
Energy & Environmental Law Update – December 11, 2012 Mintz
Jan
20
2013
Climate Change: Emerging Law of Adaptation Mintz
Mar
16
2013
State Department Announces $6 Billion for Geothermal in Southeast Asia Mintz
Jun
4
2013
Delta Finds Reprieve in State Court, but Not Everyone Will Get to Fly the Friendly Skies Mintz
Jun
22
2021
Energy & Sustainability M&A Activity — June 2021 Mintz
Aug
9
2013
Deepwater Wind, Wins First Federal Auction for Commercial Offshore Wind Development Mintz
Jul
20
2018
CMS Proposes to Reduce Payments for New Drugs under Medicare Part B Mintz
Oct
24
2013
Don’t Discount Computer-Related Inventions from Patentability Mintz
Apr
8
2014
Saas, PaaS and the Cloud? Part 2: Top 5 Considerations for Purchasing Hosted Services - Software/Platform-as-a-Service Mintz
Jan
25
2022
OIG Approves Online Retailer’s Discount Program Mintz
Feb
20
2019
Independent Laboratory Settles Medical Necessity Allegations Mintz
Sep
22
2014
Guilty Convictions in Salmonella Trial May Signify Landmark in Criminal Food-Safety Prosecutions Mintz
Apr
3
2019
CMS’s New Part D Policies Address the Opioid Epidemic Mintz
Oct
23
2014
California Battle of the Experts Still Brewin’ in Starbucks Trial Mintz
Nov
20
2014
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices Mintz
May
16
2019
FDA Finalizes Guidance on Biosimilar Interchangeability, Reiterates Case-by-Case Approach to Data Requirements Mintz
Jun
22
2022
EPA follows the first rule of holes in its eighth attempt to determine the reach of the Clean Water Act Mintz
Aug
10
2022
Senate Democrats Pass Long-Awaited Drug Pricing Reforms in Budget Reconciliation Bill Mintz
Mar
21
2015
District Court Rules Against Amgen’s Motion for Preliminary Injunction to Prevent Marketing of Sandoz’s Biosimilar Zarxio Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins